PPA
MXCT icon

Parametric Portfolio Associates’s MaxCyte MXCT Stock Holding History

Parametric Portfolio Associates’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$858K Buy
122,765
+46,709
+61% +$319K ﹤0.01% 2846
2021
Q4 		$775K Buy
76,056
+25,653
+51% +$275K ﹤0.01% 2887
2021
Q3 		$615K Buy
+50,403
New +$760K ﹤0.01% 3011

Other funds holding MXCT

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
RGI
River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Parametric Portfolio Associates's MXCT Position: Q1 2022 in Review

Parametric Portfolio Associates increased its MaxCyte (MXCT) stake by 61% in Q1 2022, buying an estimated $319K and bringing the position to 122,765 shares worth $858K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Parametric Portfolio Associates first reported a position in MXCT in Q3 2021 and has held it in 3 quarters since. 98 funds tracked by Wall St. Rank hold MXCT as of Q1 2022.

  • Parametric Portfolio Associates held 122,765 shares of MaxCyte worth $858K as of Q1 2022.
  • Parametric Portfolio Associates bought 46,709 MaxCyte shares in Q1 2022, an estimated $319K.
  • MaxCyte made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2846 holding.
  • Parametric Portfolio Associates first reported a position in MaxCyte in Q3 2021 and has held it in 3 quarters since.
  • 98 funds tracked by Wall St. Rank held MaxCyte as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.